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Background
Functional nanomaterials are used for various biomedical applications, and it is impor-
tant to devise a safe and cost-effective alternative approach for targeted cancer therapy. 
Abstract 
Background: Functionalized gold nanoparticles are emerging as a promising nano-
carrier for target specific delivery of the therapeutic molecules in a cancer cell, as a 
result it targeted selectively to the cancer cell and minimized the off-target effect. The 
functionalized nanomaterial (bio conjugate) brings novel functional properties, for 
example, the high payload of anticancer, antioxidant molecules and selective targeting 
of the cancer molecular markers. The current study reported the synthesis of multifunc-
tional bioconjugate (GNPs-Pep-A) to target the cancer cell.
Methods: The GNPs-Pep-A conjugate was prepared by functionalization of GNPs with 
peptide-A (Pro-His-Cys-Lys-Arg-Met; Pep-A) using thioctic acid as a linker molecule. The 
GNPs-Pep-A was characterized and functional efficacy was tested using Retinoblas-
toma (RB) cancer model in vitro.
Results: The GNPs-Pep-A target the reactive oxygen species (ROS) in RB, Y79, cancer 
cell more effectively, and bring down the ROS up to 70 % relative to control (untreated 
cells) in vitro. On the other hand, Pep-A and GNPs showed 40 and 9 % reductions in 
ROS, respectively, compared to control. The effectiveness of bioconjugate indicates 
the synergistic effect, due to the coexistence of both organic (Pep-A) and inorganic 
phase (GNPs) in novel GNPs-Pep-A functional material. In addition to this, it modulates 
the mRNA expression of antioxidant genes glutathione peroxidase (GPX), superoxide 
dismutase (SOD) and catalase (CAT) by two–threefolds as observed.
Conclusions: The effects of GNPs-Pep-A on ROS reduction and regulation of anti-
oxidant genes confirmed that Vitis vinifera L. polyphenol-coated GNPs synergistically 
improve the radical scavenging properties and enhanced the apoptosis of cancer cell.
Keywords: Antioxidant peptide, Conjugate, Cancer cell, Gold nanoparticles (GNPs), 
Oxidative stress, Reactive oxygen species (ROS)
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Functionalized gold nanoparticles (GNPs) as an emerging and promising nanocarrier, 
particularly for the application in nanoparticle-mediated targeted therapy, have shown 
a significant progress in cancer therapy and diagnosis. Among all nanomaterials, GNPs 
are more promising due to their unique physicochemical properties, such as biocom-
patibility, surface plasmon resonance (SPR), and ability to functionalize with amine 
and thiol groups (Choi et al. 2010; Koshevoy et al. 2011). The therapeutic efficacies of 
GNPs were demonstrated by various studies which include the multifunctionality and 
specific interaction of target moieties, such as peptide, antibody, DNA/RNA, and drug 
with cellular molecular markers (Delong et al. 2010; News and Views in 2010; Thundi-
madathil 2012). The peptide favors therapeutic application due to its small size, ease of 
synthesis, tumor-penetrating ability, bioavailability, and good biocompatibility (Agyei 
and Danquah 2011; Gu et al. 2012; Prades et al. 2012). Peptides such as cell-penetrat-
ing peptides, therapeutic peptides, and antioxidant peptides have been reported earlier 
for cancer therapeutic applications (Thundimadathil 2012; Flora and Pachauri 2010 ; 
Farkhani et  al. 2014). The antioxidant molecules increase hydrogen peroxide levels, 
scavenge reactive oxygen species (ROS), and induce cancer cells to undergo apoptosis 
(Turkevich 1951). Thiol-based antioxidant systems are present in mammals to provide 
antioxidant property and, therefore, antioxidant molecules are important molecules for 
disease prevention (Valko et al. 2006; Zeng et al. 2015).
The redox imbalance in a cancer cell is correlated with the oncogenic stimulation and 
important indicator of the disease progression. Therefore, it has considered as a pro-
tumorigenic signaling molecule that, involved in the initiation, progression and metas-
tasis of cancers (Maeda 2009; Valko et  al. 2007; Storz 2005; Droge 2002; Finkel 2003; 
Kimura et  al. 2005). Hence, modulating the redox state of the cancer cell is an inter-
esting area of study for cancer therapy. Several studies reported the nanocarrier-based 
targeting of the cancer biomarkers such as, transforming growth factor-beta-1 (TGF-
β1), transmembrane receptor P185(HER2) for targeted cancer therapy, to our knowl-
edge, none of these studies utilized to target the ROS using antioxidant peptide (Pep-A) 
(Prades et al. 2012; Tsai et al. 2013; Kodiha et al. 2015). Hence, it is imperative to develop 
a suitable biocompatible functionalized nanomaterial for specific and effective targeting 
the cancer tissue.
In this study, we used RB cancer model for targeting the ROS, by means of the anti-
oxidant peptides (Pep-A) which contain alternative aromatic or sulfur-containing amino 
acid. The side chains of Pep-A are believed to contribute to strong radical scavenging 
activities of peptides in the cancer cell. Toward achieving this aim, we design novel mul-
tifunctional strategies to attain more specific and effective response. The application of 
antioxidant molecule alone for targeted therapy has limited its application due to bio-
availability and stability in biological environment, limitations of which prompted this 
research of utilizing nanocarrier-mediated delivery, as it could play a pivotal role of 
being an effective therapeutic agent. Hence, GNPs-Pep-A composite was synthesized 
using thiotic acid (TA), an antioxidant linker molecule. Thiotic acid improves the metal-
chelating capacity, radical scavenging, and improves the antioxidant effect. The GNPs 
synthesized by Vitis vinifera, L is chosen for the delivery of Pep-A due to several advan-
tages associated with the natural polyphenols used in the synthesis processes: (1) antiox-
idant and anticancer property, (2) reduced chemical and metal toxicities (3) synergistic 
Page 3 of 19Kalmodia et al. Cancer Nano  (2016) 7:1 
improvement in the antioxidant effect of Pep-A, and (4) most importantly, decrease in 
the nanoparticle-mediated ROS induction (Sharma et  al. 2011). The current findings 
indicate that bioconjugate (GNPs-Pep-A) shows therapeutic efficacy by quenching the 
ROS species in the cancer cells. The antioxidant potency of bioconjugate to target the 
ROS is owing to the co-existence of different phases in a conjugate (GNPs-Pep-A).
Although a number of nanocarrier-based approaches have emerged for cancer ther-
apy, this study is an aid for ROS-mediated targeted therapy. It is an effective and safe 
approach for the diseases like cancer which are highly heterogeneous in nature. Thus, 
the current study provides a rational plan with an alternative to conventional peptide-
functionalized targeted therapy, which would be an effective strategy in the clinical man-
agement of cancer.
Methods
Evaluation of antioxidant effect of peptides A and B (Pep‑A and Pep‑B)
Two short peptides, Pep-A and Pep-B, were selected and evaluated for antioxidant effi-
ciency by measuring their effects on cellular reactive oxygen species (ROS) and super-
oxide dismutase (SOD) enzyme activity on cultured Y79 retinoblastoma cells. The 
antioxidant peptides, Pep-A: Pro-His-Cys-Lys-Arg-Met (PHCKRM) and Pep-B:Thr-Arg-
Asn-Tyr-Tyr-Val-Arg-Ala-Val-Leu (TRNYYVRAVL), were procured from AnaSpec, Bi 
Biotech India Pvt Ltd, New Delhi. The thiotic acid-modified Pep-A peptides were cus-
tom synthesized by Custom Peptide Synthesis, USV limited India, CPS 1514-1. The pep-
tides were HPLC purified to obtain >95 % purity.
Cell culture
Y79 retinoblastoma cell line (RCB1645) was obtained from RIKEN BioResource Center 
cell bank (Ibaraki, Japan) and maintained with an atmosphere containing 5  % CO2 at 
37 °C in RPMI 1640 media (Sigma-Aldrich, USA) with 10 % FBS. After it attains 80–90 % 
confluence, the cells were used for all the in vitro experiments. Muller-glial (MIOM1) 
cell line derived from the neural retina (Limb et al. 2002) was grown in DMEM media 
supplemented with 10 % FBS and maintained at 37 °C with 10 % CO2. Muller-glial cell 
line was a gift from Dr. G. A. Limb, the Institute of Ophthalmology, University College, 
London.
Measurement of intracellular ROS levels on peptide treatment using 2′, 7′ 
Dichlorodihydrofluorescein (DCF) assay
The intracellular ROS levels were measured using an OxiSelect ROS Assay Kit (Cell Bio-
labs Inc, CA, USA) as per the manufacturer’s instructions. Y79 cels, RB cell lines, were 
seeded at 7 × 103 cells/well in 96-well plates and incubated at 37 °C overnight. Then, the 
cells were washed thrice with sterile PBS and treated with 100 μl of 1X DCFH-DA (2′, 
7′-Dichlorodihydrofluorescin diacetate) for 1 h at 37 °C. The solution was removed, and 
the cells were washed with sterile PBS and treated with varying concentrations (rang-
ing from 10 to 100 µM) of Pep-A and B for 24 h. The reaction was terminated by adding 
100 μl of cell lysis buffer, mixed thoroughly for proper cell lysis, and incubated for 5 min. 
The fluorescence was read on a Spectra Max M4 multi-detection micro plate reader 
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(Molecular devices, CA, USA) at 480-nm excitation/530-nm emission. The ROS levels in 
cell lysates were then calculated using the DCF standard curve.
SOD activity measurement
Y79 cells were seeded at 2 × 105 cells/well in 12-well plates with 1000 μl of culture media 
and incubated at 37  °C overnight. The cells were then exposed to varying dosages of 
Pep-A and Pep-B (10, 50, and 100 μM) in fresh medium and then incubated for 6 h. At 
the end of the incubation, the cells were collected and washed with ice-cold PBS twice 
and lysed with cell lysis buffer [0.1 M Tris/HCl, pH 7.4 containing 0.5 % Triton X-100, 
5 mM β-Mercaptoethanol, 0.1 mg/ml PMSF]. Cell lysate was centrifuged at 14000×g for 
5 min at 4 °C. The supernatant contains a combined SOD activity from cytosol and mito-
chondria. The SOD activity was measured using the superoxide dismutase (SOD) activ-
ity assay kit, (BioVision, CA, USA, Sigma Aldrich, MO, USA) as per the manufacturer’s 
instructions. In brief, the cell lysate, buffer, enzyme, and the WST reagent were diluted, 
and the solution was added as per the protocol and incubated at 37 °C for 20 min and 
read at 450 nm on a microplate reader (Biotek, VT, USA). SOD activity was then calcu-
lated as a percentage of the inhibition activity of xanthine oxidase.
Cytotoxicity assay
Y79 retinoblastoma and MIOM1 cells were seeded at 5 × 103 cells/well in 96-well plates 
and incubated at 37  °C overnight. The cells were then treated with varying concentra-
tions (10, 30, 60, and 100 µM) of Pep-A and Pep-B in a fresh medium and incubated for 
specific time periods (24 and 48 h). At the end of the incubation, 10 µl of MTT [3-(4, 
5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide; 5  mg/ml] was added to the 
cells with fresh medium (100  µl) and incubated at 37  °C until formazan crystals were 
formed. The formazan crystals were dissolved in 100 µl of DMSO, and the reading was 
taken at 570 nm (BioTek, ELISA, USA). Cell viability was calculated as Test OD/Control 
OD × 100.
Preparation of bioconjugate (GNPs‑Pep‑A)
The filtered GNPs were used to prepare the bioconjugate (GNPs-Pep-A), and the con-
jugation protocol was followed as described by N. Chanda et al (Chanda et al. (2010). 
The thiotic acid (TA)-modified peptide conjugates with GNPs in different ratios of 
peptides, for example, GNPs:Pep-A1 [(18  ml GNPs: 1.7  mg) and GNPs:Pep-A2 (18  ml 
GNPs: 4.3 mg)] were used. The conjugates were prepared using 18 ml of GNPs (OD520 
nm = 1.00), [2.32 × 10−9, Molar particles/L, (242 × 10−6, Moles of gold/L)] mixed with 
4.3 mg of Pep-A dissolved in 1 ml of water and kept under stirring overnight. A simi-
lar protocol was followed for the preparation of other conjugate, and the synthesized 
conjugate was subjected to purification. GNPs-Pep-A was washed twice by centrifuga-
tion at 15,000 rpm for 30 min with distilled water to remove unattached peptides on the 
surface of the gold. The thiotic acid (TA) has sulfur-containing antioxidant linker mol-
ecules that bind with GNPs to form Au–S bond between peptide and GNPs (Yin 2007). 
The GNPs-Pep-A was pelleted, and the supernatant was measured for the presence of 
peptide by reading the absorption at 280 nm. The 50 µM was the final concentration of 
Page 5 of 19Kalmodia et al. Cancer Nano  (2016) 7:1 
GNPs-Pep-A which was used for the in vitro studies. The conjugate (GNPs-Pep-A) con-
centration was measured using the GNP’s concentration.
In vitro stability of GNPs‑Pep‑A
The stability of GNPs-Pep-A was studied in a variety of solvents and buffers using previ-
ously reported methodology (Kalmodia et al. 2013). One ml of GNPs-Pep-A was mixed 
with 0.5 ml (10 mM) each of DTT, cysteine, histidine, and NaCl; also, GNPs alone was 
used as a reference. The solutions were then incubated for 2 h at room temperature, and 
the stability of the GNPs-Pep-A was determined using UV–Vis spectrophotometer (DU 
800 Spectrophotometer, Beckman Coulter Inc, CA, USA).
UV–Vis spectroscopy of GNPs‑Pep‑A
The GNPs-Pep-A were characterized using UV–Visible spectroscopy (Molecular device-
M4, CA, USA) to observe the surface plasmon resonance (SPR) with respect to the 
GNPs. The spectra were obtained in the range of 400–800 nm using water as a blank.
FT‑IR characterization of GNPs‑Pep‑A
The lyophilized GNPs-Pep-A was subjected to Fourier transform-infrared spectrum 
(FT–IR) analysis for characterizing the functional groups using an FT–IR Spectrome-
ter (Vortex 70 BRUKER, Billerica, MA 01821, USA). The samples were mixed with KBr 
powder, pulverized, and formed into a disk-shaped pellet. FTIR spectra were recorded in 
the frequency range of 500–4000 cm−1 in transmittance mode.
Size and zeta potential measurement by dynamics light scattering (DLS) of GNPs‑Pep‑A
The average hydrodynamic size (Z average), size distribution (% number distribu-
tion), and zeta potential of GNPs-Pep-A as a colloidal suspension were measured using 
dynamic light scattering (DLS) and a Zetasizer [Nano-ZS model equipped with 4.0 mW, 
633 nm laser, Model ZEN3600, serial no. MAL1024433, Malvern Instruments Ltd., Mal-
vern, UK]. The particle size was determined based on the Brownian motion relating to 
the size of the particles suspended in a liquid.
Uptake and internalization by fluorescent‑activated cell sorter (FACS)
The Y79 cells were seeded on the lysine (0.01 mg/ml)-coated glass slide. The cells were 
cultured overnight and treated with different concentrations (50 or 100 µM) of FITC-
tagged Pep-A for 4 h, for studying the localization and internalization of the peptide by 
fluorescence microscopy. The FITC-labeled peptide A molecules (molecular mass 771.2) 
were custom synthesized (CPS 1468-1, custom peptide synthesis, USV limited India) 
with ~95 % purity obtained by HPLC method. The GNPs and GNPs-Pep-A conjugates 
were doped with the R6G dye as described by Kalmodia et  al., for the internalization 
study (Kalmodia et al. 2013). The internalization of the peptide, R6G-doped GNPs and 
GNPs-Pep-A after 4  h was qualitatively detected by Zeiss LSM, 710 laser microscope 
supplied by Axio vision (Germany). The peptide uptake was performed by flow cytomet-
ric analysis to confirm the concentration-dependent uptake of the peptide in cell culture 
in vitro. Y79 cells were seeded at 2 × 105 cells/well in six-well plates and treated with 
50 and 100 µM concentrations of Pep-A for 4 h. The cells were then spun at 1500 rpm 
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for 5 min, washed with PBS buffer, and then resuspended in FACS buffer. The cells were 
then analyzed for uptake of the peptide using FACS Calibur (BD Biosciences, CA, USA) 
by means of CELL QUEST PRO software. The fluorescence of FITC-stained cells was 
excited with an argon laser at 488 nm, and the emissions were detected at 530 nm. The 
overlay graph and scattered plot were used to confirm the FITC positive cell population.
Functional effects of GNPs‑Pep‑A
Cytotoxic effects of GNPs and Pep-A were evaluated by MTT assay as per the protocol 
described in “Cytotoxicity assay” section. Antioxidant effects of GNPs-Pep-A, bioconju-
gate were evaluated by measuring the cellular ROS and SOD enzyme activity by similar 
methods as described in “Measurement of intracellular ROS levels on peptide treatment 
using 2′, 7′ dichlorodihydrofluorescein (DCF) assay” and “SOD activity measurement” 
sections, respectively. In these assays, the peptides were replaced with the GNPs and 
GNPs-Pep-A. For evaluating the effects of GNPs-Pep-A on mRNA expressions of anti-
oxidant genes—superoxide dismutase (SOD), glutathione peroxidase (GPX), and cata-
lase (CAT)—retinoblastoma cells (Y79) were seeded at a density of 1 × 106 cells/well, 
and treated with GNPs and GNPs-Pep-A for 24 h. Total RNA was isolated using Trizol, 
and concentration of RNA was quantified using a Nanodrop (Biospec-Nano,Shimadzu, 
Biotech, Japan). The total RNA was converted into cDNA using an Applied Biosystem 
kit (High-Capacity cDNA Transcription Kit, USA). Quantification of target gene expres-
sion was performed in triplicate in a 20-µl reaction mixture containing 0.1 µg of cDNA, 
specific primers (Table 1), and SYBR green reagent in 96-well plates on a real-time PCR 
system (Applied Biosystems, Singapore). GAPDH and β actin were used as internal con-
trols, and the detection was carried out by measuring the binding of fluorescence dye 
SYBR green to double-stranded DNA. After cycling, relative quantitation of the tested 
gene cDNA against the internal control was performed using the ΔCT method. The rela-
tive amount of gene-specific mRNA to housekeeping gene was calculated using 2−ΔΔCt, 
where Ct, the number of cycles at which amplification reaches a threshold, is determined 
using SDS software version 1.3.
Statistical analysis
The in vitro data were analyzed by one-way ANOVA using SPSS-17 software, and the 
post hoc test was performed for multiple comparisons. Student’s unpaired t test was 
used for statistical comparisons, and P < 0.05 was considered significant.
Table 1 Primer sequences for target genes used in qRT-PCR
Gene Primer sequence Product size
Catalase (CAT) FP 5′- TCTGGAGAAGTGCGGAGATT-3′
RP 5′- AGTCAGGGTGGACCTCAGTG-3′
190 bp
Superoxide dismutase 1 (SOD1) FP 5′- GATGAAGAGAGGCATGTTGGAGAC-3′
RP 5′- GTCTTTGTACTTTCTTCATTTCCACC-3′
186 bp
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Results and discussion
The results obtained in the current study highlights the significance of bioconjugates on 
free radical scavenging property. The peptide-functionalized GNPs reduce the metal ion 
toxicity owing to peptide coating on the GNPs surface. The bioconjugate provides the 
stability to peptide and also imparts new functionalities in the synthesized GNPs-Pep-
A. It shows the large synergistic effect on ROS reduction due to the coexistence of the 
two phases in close proximity, although the chemical reactivity of individual phase is 
significantly different from the other (Sanchez et al. 2011). It has been reported that the 
organic–inorganic conjugate material retains its original property and helps to maintain 
its stability, thermal behavior, aqueous solubility, and shows novel properties (Sanchez 
et  al. 2005). Figure  1, a schematic illustration, illustrates preparation of GNPs-Pep-A 
conjugate and its radical scavenger capability in cancer cell.
In vitro antioxidant activities of peptide A and peptide B
The antioxidant activities of two peptides were determined by measuring the intracellu-
lar ROS levels and the cellular principal antioxidant enzyme, and superoxide dismutase 
(SOD) activity. Reactive oxygen species (ROS) are formed as a by-product during nor-
mal cellular metabolism and also during physical and environmental stress to the cell. 
These ROS cause damage to DNA, oxidize amino acids and lipids, and inactivate impor-
tant enzymes. Cells scavenge these species with the help of first-line defense enzymes: 
Glutathione peroxidase (GPX), catalase (CAT), and superoxide dismutase (SOD). There-
fore, ROS levels and the key antioxidant members were estimated for peptide treatments 
to understand their roles in the regulation of cellular oxygen stress. Pep-A showed a 
Fig. 1 Schematic of GNPs -Pep-A synthesis and antioxidant effect. GNPs-Pep-A synthesis. Schematic presen-
tation of chemical reaction for functionalization of GNPs with thiotic acid-modified Peptide-A and its effect in 
cancer cell in vitro
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dose-dependent inhibition of ROS levels ranging from 4 to 40  % relative to untreated 
control. In contrast, Pep-B showed inhibition in the range of 32–38 %, and the inhibi-
tion levels were inconsistent (Fig.  2a). Methionine and cysteine in our peptides may 
donate sulfur and hydrogen making them effective free radical scavengers compared to 
Pep-B. In agreement with the observed results, in earlier studies also, proteins and pep-
tides with sulfur-containing amino acids and aromatic side chains have been reported as 
effective regulators of the oxidative damage (Elias et al. 2008).
The effects of 10–100 μM of Pep-A concentrations were studied on the SOD enzyme 
activity. The enzyme activity decreased by 0.5 and 0.7-folds at 10 and 50 µM Pep-A con-
centrations, respectively (Fig. 2b), and increased by 1.79-folds at 100 µM Pep-A treat-
ment, indicating that this concentration could be ideal for the treatment on Y79 a, RB 
cells (Fig. 2b). Furthermore, the Pep-A could be involved in decreasing the ROS (Fig. 2a) 
by increasing the antioxidant enzyme activity. A similar increase in the antioxidative 
enzyme levels in the presence of Hoki skin antioxidative peptide in hepatocarcinoma 
cells is attributed to the peptide’s role in maintaining the redox balance in the cellular 
environment (Jridi et al. 2014). The concentration- and time-dependent effects of inhibi-
tion of Lypooxigenase 12 enzyme levels by a peptide were reported in the breast cancer 
cells. This study suggested that the therapeutic effect of the peptide depends on con-
centration, cell line, and the duration of treatment (Singh et  al. 2012). Pep-B used in 
Fig. 2 Evaluation of antioxidant activities of Pep-A and Pep-B, inhibitions of ROS and SOD levels by antioxi-
dant peptide A. a Antioxidant activities of Pep-A and Pep-B were evident from the decrease in ROS levels in 
Y79 RB cells on peptide treatment. The percentage decrease in ROS levels relative to untreated control can 
be noticed. * indicates the significant difference at P < 0.05 relative to 10 µM of peptide A. b Antioxidant Pep-
A- and Pep-B-treated Y79 RB cells showed initial decrease in SOD activity when treated at 10–50 µM, and at 
100 µM, the enzyme activity increased. SOD activity was calculated as a percentage of the inhibition activity 
of xanthine oxidase and depicted as increase/decrease relative to untreated control. Data points indicate 
mean ± SEM of duplicate values. * indicates the significant difference at P < 0.05 relative to 50 µM of Pep-A
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the study did not show any increased SOD enzyme activity at different concentrations 
(Fig. 2b), indicating that this peptide did not elicit any change in the cellular antioxidant 
enzymes. Therefore, further work is carried out using Pep-A. The hybrid bio-nanoparti-
cle is synthesized using GNPs, 100 µM Pep-A, and thiotic acid as linker molecules. The 
concentration of the peptide used was 100 µM which was found to be effective to elicit 
the antioxidant enzyme response by this peptide (Fig. 2b).
Characterization of bioconjugate (GNP‑Pep‑A)
The presence of the peptide on the GNPs was studied using DLS, FTIR, and UV–Visible 
spectroscopy (Fig. 3 a and c). The surface plasmon absorbance band peak of GNPs shows 
a Red shift at 540 nm after the addition of Pep-A (Fig. 3a). The similar red shift in the 
surface plasmon absorbance peak was observed after the binding of cysteine molecules 
to the GNPs. The red shift in plasmon absorbance is attributed to the presence of pep-
tides on GNPs (Maus et al. 2010).
The Pep-A bind to GNPs, which is evaluated by means of FTIR vibrational spectros-
copy as this method gives specific vibrational patterns for the ligand bound to GNPs 
(Tiwari et  al. 2014). Spectroscopic analysis of GNPs-Pep-A by FTIR (Fig.  3c) showed 
vibrational bands at 3446–2365, 2620, and 1641–663 cm−1. The presence of 1641 and 
1669 cm−1 bands in the FTIR spectra of Pep-A and GNPs-Pep-A confirms the presence 
of the amide bonds. The peptide coating on the GNPs exhibited a characteristic IR band 
at 3448 cm−1, indicating the presence of O–H and COOH moieties, whereas 2920 and 
2854 cm−1 bands can be assigned to the symmetric and anti-symmetric vibration bands 
for CH2 and CH3 groups and C = O stretching of an amide I. In a previous study, COO− 
bands assigned at 1600 and 1390 cm−1are asymmetric and symmetric, whereas a band 
at a broad range 3000–3500 cm−1 range was assigned for NH3+of amino acid (Khlebt-
sov 2011). The GNPs-Pep-A nanoparticles showed significant peak shift from 1641 to 
1669 cm−1 compared to Pep-A alone indicating the effect of metal surface on selective 
surface–induced functional group shift. Similar changes in vibrational modes in the 
presence of metallic nanoparticles have been observed before (Alexander et  al. 2002). 
The shift in the vibration peak intensities may indicate covalent binding of Pep-A to the 
GNPs to form GNPs-Pep-A (Aryal et al. 2006). The peaks at 2129 and 2365 cm−1 in the 
spectra of the Pep-A indicate S–H bond in the peptide molecule, whereas the disappear-
ance of these peaks in GNPs-Pep-A may suggest the absence of S–H bonds and the pres-
ence of the Au–S bond (Kalmodia et al. 2013).
Stability of the GNPs‑Pep‑A
The number and size distribution of GNPs-Pep-A particles were measured by DLS. The 
size of the nanoparticles was in the range of 10–22  nm (Fig.  3a and 4b), whereas the 
zeta potential of GNPs was in the range of −17 to −21 mV (Table 2). The high nega-
tive potential indicates that the nanoparticles are stable. The hydrodynamic size of the 
GNPs is 49.6 ± 0.4 nm, and the size increased to 91.7 ± 1.7 in GNPs-Pep-A nanopar-
ticles. The increase in hydrodynamic size could be due to the presence of peptide mol-
ecules capped on the surface of the GNPs (Table 2). The DLS measurements (Fig. 3a) 
indicate a monodispersion of GNPs-Pep-A in the solvent water (Aryal et al. 2006). The 
increase in hydrodynamic size of the GNPs after conjugation to bombesin peptide has 
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been reported earlier (Chanda et al. 2010). The increasing bombesin peptide concentra-
tion on the GNPs increased the hydrodynamic size of the nanoparticles (Au–BBN-1115, 
Au–BBN-2137, and Au–BBN-2, 155), whereas the core size of nanoparticles was found 
to be16 ± 7 nm. Similarly, the zeta potential of the GNPs-Pep-A (−26.5 ± 0.2) is larger 
than that of GNPs alone (−22.5 ± 0.2 mV), indicating a greater stability of these nano-
particles than the GNPs in vitro. (Table 2).
Fig. 3 Characterization of GNPs-Pep-A by UV–visible spectra of GNPs and conjugate. a The graph shows a 
shift in SPR for GNPs-Pep-A (black which is actually not visible but is merged with green line), and for GNPs-
Pep-A in different buffers, no alteration in the shift confirms the stability of the conjugate in vitro; b size 
distribution of GNPs-Pep-A (Inset: GNPs); c the FTIR spectral difference and the functional group confirming 
GNPs-Pep-A conjugate formation
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Fig. 4 Cell uptakes of antioxidant peptide A in Y79 RB cells evaluated by flow cytometry. a Untreated Y79 RB 
cells, b and c cells treated with 50 and 100 µM of Pep-A showing maximum (99 %) number of FITC positive 
population in M2. d Overlay picture showing peptide uptakes in control and treated Y79 RB cells
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The stability of the GNPs-Pep-A was tested in different solvents using UV–Visible 
spectroscopy and DLS measurements (Fig. 3a and b). The absorption peak of GNPs-Pep-
A at 540 nm remained unaltered in various solvents except for the solvent-containing 
histidine which shows increase in absorbance (Fig. 3a) indicating the binding activity to 
form GNPs-Pep-A hybrid. The histidine has a positive charge on its imidazole functional 
group which brings about changes in the binding affinity with the metal nanoparticles 
(Flora and Pachauri 2010). The zeta potential of GNPs-Pep-A-His (32.0 ± 0.25) is higher 
than GNP-Pep-A(−32.0 ± 0.25) indicating a greater stability in the presence of histidine 
(Table  2). The sulfur-containing amino acid cysteine and DTT also increased the zeta 
potential to −36.96 ± 1.17 and −35.4 ± 3.95, respectively (Table 2). The cystine amino 
acid could increase the acidity of the solution thereby increasing the zeta potential of 
the nano particle as evident from the increased potential in the presence of DTT and 
amino acid. In the presence of high ionic strength salt NaCl, the zeta potential does not 
alter. The conjugated Pep-A to GNPs maintains the electric double layer of the GNPs 
and decreases the probability of the salt Na+ ions to cause any aggregation to the hybrid 
(Bei et al. 2011; Liu et al. 2007). Thus, the GNPs-Pep-A is stable in various biologically 
relevant solutions, making these characteristics suitable for their potential applications.
Internalization and uptakes of Pep‑A, GNPs‑Pep‑A, and GNPs
The Peptide-A (Pep-A) uptake was measured by the FACS (fluorescence-activated cell 
sorter) and microscope using Y79 cells, RB cell line (Figs. 4, 5). The FACS analysis results 
for Pep-A showed a concentration-dependent uptake into the Y79 cells. The histogram 
statistic indicates that there is a significant shift in the FITC positive population (Fig. 4 a, 
X-axis) from M1 to M2. In the control samples (cells without Pep-A), M1 population is 
99.99 whereas the M2 population is 0.01; in the case of 50 µM of Pep-A, M1 population 
is 99.97, whereas the M2 population is 0.03. Similarly, in 50 µM of Pep-A, M1 population 
is 99.95, and the M2 population is 0.05. The shift of the population from M1 to M2 in 
the peptide is an indication of the peptide internalization. In addition to the histogram 
statistic, overlay graph (Fig.  4 b) further confirms the concentration-dependent inter-
nalization of the peptide into the Y79 RB (Fig. 4b). The increase in the number of counts 
(Y axis, Fig.  4 b), as well as the FITC positivity M2 population compared to the con-
trol, indicates that peptide is internalized by the Y79 cells (Hällbrink et al. 2004). It has 
been reported that the uptake of the peptide is mainly by CPP (cell-penetrating peptide) 
that follows the endocytotic pathways, endocytosis, macropinocytosis, and clathrin-
mediated endocytosis. The proteoglycan contributes mostly to facilitate internalization 
Table 2 Effects of different solvents on stability of GNPs-Pep-A
Sample Zeta potential (mV) Z Average (hydrodynamic size)
GNPs −22.5 ± 1.77 49.6 ± 0.4
Conjugate (GNPs-Peptide A) −26.5 ± 2.02 91.17 ± 1.17
DTT + conjugate −35.4 ± 3.95 92.36 ± 0.30
NaCl + conjugate −22.6 ± 1.98 89.48 ± 0.31
Cysteine + conjugate − 91.05 ± 0.99
Histidine + conjugate −32.0 ± 0.25 95.96 ± 0.88
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of the peptide by increasing the concentration of the peptide at the membrane surface by 
enhancing the recruitment of peptide via electrostatic interactions and helps in reorgan-
ization of the F-actin to facilitate the internalization of the peptide (Kosuge et al. 2008). 
The amino acid composition also significantly alters the internalization of the peptide 
(Amand et al. 2012). Arginine is an important amino acid, which enhances the internali-
zation of the peptide;this could be due to the cationic nature of arginine, which disrupts 
the membranes of macropinosomes, and this may lead the peptides into the cytosol. 
Alternatively, hydrophobic counter-anion molecules may help the translocation of argi-
nine peptides into the cytosol. In the case of Pep-A (PHCKRM), the P (Proline) and M 
(Methionine) amino acids are hydrophobic in nature which could help in internalization 
of peptide in addition to the arginine (R) (Guterstam et al. 2009). The internalization of 
the nanoparticles is further visualized by the presence of red fluorescent signal from the 
cells treated with the R6G dye-doped GNPs and GNP-Pep-A nanoparticles (Fig. 5 panel 
3 and 4). The R6G-doped GNPs have been successfully detected by fluorescence due to 
presence of dye on the surface of metals (Chen et al. 2007). In our current results, the 
GNPs (Fig. 4 panel 3) and GNPs-Pep-A (Fig. 5 panel 4) show red fluorescence of R6G 
dye on GNPs. However, when FITC-conjugated peptide was attached to GNPs, green 
fluorescence from the dye was not observed (Fig. 5 panel 4). This could be due to the 
fluorescence quenching by the proximity of the metal atoms in GNPs (Oishi et al. 2009).
The optical microscopic images of the Y79 cells, RB cell line, treated with the peptide, 
GNPs, and GNPs-Pep-A (Fig. 5) show the morphological differences compared to the 
untreated cells. The cells treated with the peptide alone (Fig. 5 panel-2) show similar-
ity in morphology as the control untreated cells (Fig.  5 panal-1), whereas the cellular 
morphologies of treated cells with GNPs and GNPs-Pep-A (Fig. 5 panel 3 and 4) showed 
Fig. 5 Cell uptake of antioxidant peptide A in Y79 RB cells evaluated by fluorescence microscopy. Micro-
graphs showing internalization of FITC-labeled peptide Pep-A after 3 h of treatment in Y79 RB cells. panel-1: 
control, panel-2: Pep-A, panel-3: GNPs, and panel-4: GNPs-Pep-A. Magnification 10 × Magnification: 10× 
(Scale bar: 10 μm)
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significant differences. The cell fragments were observed, indicating apoptotic bodies 
formed during the process of membrane cell death. The clustering of cells, shrinkage, 
change in size, and condensation of cytoplasm is in accordance with the apoptotic or 
necrotic cell death and are the most commonly observed microscopic features (Barros 
et al. 2003). The better performance of the GNPs and GNP-Pep-A compared to the pep-
tide alone in apoptosis of cancer cells indicates the potential application of nanoparticles 
in cancer therapy.
Antioxidant function of GNPs and GNPs‑Pep‑A
The functional activities of the GNPs and GNPs-Pep-A were studied after establish-
ing the uptake and internalization of these particles into the Y79 cells. The GNPs-Pep-
A shows the cooperative effect due to the different functional moieties present in the 
structure of the conjugate. Therefore, ROS levels and the key antioxidant members were 
estimated for GNPs and GNPs-Pep-A treatments to understand their roles in the reg-
ulation of cellular oxygen stress. The effective concentration of Pep-A for scavenging 
ROS was found to be 100 µM (Fig. 2), and hence, the ROS levels were measured at this 
peptide concentration. ROS levels decreased significantly (75 % at P < 0.05) with GNPs-
Pep-A compared to the GNPs alone (9 %) (Fig. 6a). There was a 66 % decrease in ROS 
species at 250  µM peptide concentration. Very high dosages of antioxidants may pre-
vent them from exerting their antioxidant action, and may also alter the biological redox 
state. Combinational therapy with multiple free radical scavengers and sustained release 
formulations is suggested for an efficient antioxidant therapy (Kohen 2002). Therefore, 
100  µM of antioxidant peptide could be the optimum dosage, which showed (Fig.  6a) 
about 30–40 % decrease in the ROS production compared to other concentrations. The 
GNPs-Pep-A nanoparticles were more efficient in scavenging ROS than their constitu-
ents (GNPs and Pep-A) (Figs. 6b and 2a), indicating a synergistic antioxidant effect due 
to the combined presence of metal and organic phases in the bioconjugate. It has been 
reported that the organic–inorganic hybrid material retains its original property along 
with the improved properties such as stability, thermal behavior, and aqueous solubility, 
and adds novel properties to the hybrid materials (Sanchez et al. 2005). In the present 
study, the GNPs-Pep-A hybrid material exhibited better stability and antioxidant capac-
ity compared to its individual constituents.
Further studies were performed to understand the reduction in ROS and its effect on 
the antioxidant enzyme gene expression. Quantitative real-time PCR analysis with GNPs 
treatment for the first-line defense antioxidant enzyme gene expression showed two-
fold downregulations of SOD and GPX, and 2.7-fold downregulation of CAT enzyme 
mRNA levels (Fig. 6d). GNPs-Pep-A showed 2.1-fold upregulation of the CAT and SOD, 
and 2.5-fold upregulation of GPX enzyme gene expression (Fig. 6d). The high up-regu-
lated gene expression level of antioxidant enzymes by GNPs-Pep-A compared to GNPs 
alone signifies that the GNPs-Pep-A could be a stronger antioxidant response regulator. 
Furthermore, the polyphenols from grapes, thiotic acid as linker molecules are syner-
gistically acting with Pep-A to decrease the oxidative stress. We further tested enzyme 
activities to confirm the effect of the gene expression. We chose estimation of SOD 
enzyme activities after the GNP and GNP-Pep-A treatments to study the inhibition 
activity for GNPs-Pep-A which was 81 % compared to 61 % for the untreated control; 
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GNPs treatment on Y79 RB cells showed 70 % reduction in SOD activity compared to 
the control (Fig. 6c). The enzyme activities are consistent with the measured SOD gene 
expression levels. The treatment of GNP-Pep-A resulted in 81 % decrease in the SOD 
enzyme activities (Fig. 6c) indicating that the compounds present in the nanoparticles 
are acting as efficient free radical scavengers bringing down the need for SOD enzyme to 
scavenge them. The enhanced antioxidant capacity of GNPs-Pep-A could be attributed 
to the presence of polyphenols on the GNPs, TA, and the presence of antioxidant pep-
tide (Khan et al. 2013). The presence of alternating aromatic and cationic amino acids in 
the peptides could provide effective antioxidant properties and efficient membrane pen-
etration (Szeto 2006). Thus, the amino acids constituent in a peptide determine its effec-
tiveness. The supra-molecular system utilizes monolayer-protected gold nanoparticles 
(GNPs) so that the antioxidants and gold nanoparticles improve its functionality. This is 
consistent with the assertion that the organic molecules in organized assemblies having 
reactivity higher than the sum of the monomers. Au@Trolox, a gold nanoparticle with 
Fig. 6 Functional studies with GNPs and GNPs-Pep-A bio conjugate. a Native GNPs treated on Y79 RB cells 
at varying dosages for 6, 12, and 24 h showed both dose- and time-dependent decreases in cell viability. # 
indicates statistical significant difference with respect to the controls for 50 µM at 24 h, whereas # indi-
cates significant differences at 6, 12, and 24 h for 100 µM with respect to control at P < 0.05. b GNPs-Pep-A 
decreased the ROS levels in Y79 RB cells effectively compared to GNPs alone and peptide alone (Fig. 2a). The 
final concentration of 50 µM GNPs (Moles of gold) used for functional study. GNPs-PepA1 and GNPs-PepA2 
contain the final concentrations of Pep-A being 100 and 250 µM, respectively. Each column indicates mean 
percentage inhibition of ROS levels from triplicate values relative to untreated control. Error bars SEM from 
triplicate values. * indicates the significant difference relative to GNPs at P < 0.05. c GNPs-Pep-A increased the 
SOD enzyme activity by 1.3-fold compared to 1.1-fold increase by GNPs alone. Each column indicates SOD 
activity (inhibition rate  %) from triplicate values. Error bars indicate SEM from triplicate values. * Represents 
the statistical significant difference with respect to control at P < 0.05; # represent the significant difference 
relative to GNPs at P < 0.005. d Y79 RB cells treated with GNPs and GNPs-Pep-A were analyzed for mRNA 
expression of first-line defense antioxidant enzymes. GNPs and GNPs-Pep-A downregulated and upregulated 
the SOD (superoxide dismutase), GPX (glutathione peroxidase), and CAT (catalase) enzymes’ gene expression 
levels, respectively. Each column indicates mean ± SEM. of duplicate values
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a Trolox (vitamin E analog)-derivative monolayer, possesses eight times higher radical 
scavenging activity compared with the Trolox monomer, indicating that the cooperative 
effect of supra-molecular assemblies also works in the area of free radical scavenging. 
Similarly, another study using Atm-deficient mice model confirmed that oxidative stress 
decreased after treatment of Atm-deficient mice with alpha-tocopherol (Erker et  al. 
2006).
Cytotoxicity assessment of Pep‑A and B
The GNP-Pep-A showed super performance as an antioxidant through ROS targeting 
compared to its constituents, Peptide A and GNPs. The 50-µM concentration of the 
GNPs shows more than 70 % of cell viability till 24 h in retinoblastoma cells; therefore, 
this concentration was considered for the in vitro functional studies. The above studies 
confirmed the GNPs-Pep-A stability and its uptake inside the Y79, RB cells (Fig. 5a). In 
addition to this, cell viability analysis results showed that the pep-A showed no toxicity 
to cancerous (Y79) cells and non-cancerous cells even after 48 h of treatment (Fig. 7a 
and c). The Y79 RB cell viability ranged between 115 and 157 % and 111–126 % after 24 
and 48 h of exposures with Pep-A, respectively (Fig. 7a). The cancer cell death from the 
treatment of 10–100 µM GNPs concentration was studied (Fig. 7a). The 100 µM GNPs 
shows cell death on Y79 RB cells at 24 h of treatment, which could be partly due to the 
presence of polyphenols of GNPs. The earlier study reported with V. vinifere that nano-
particles were not toxic to breast cancer (MDA-MB-453) and non-neoplastic MIOM1 
cells, indicating that the cytotoxicity of the nanoparticle could be cell-type specific (Kal-
modia et al. 2013). The antiproliferative nature of GNPs in the retinoblastoma cell line 
could be due to the S-phase arrest leading to cell death in the presence of the polyphe-
nols presented on the surface of GNPs.
The cancer cells are known to have elevated ROS and altered signaling mechanisms 
compared to normal cells. The elevated ROS in the cancer cells needs more efficient anti-
oxidants to kill the cells. The GNP-Pep-A bioconjugate was a better antioxidant (Fig. 6) 
interacting with elevated ROS in the cancer cells causing changes in cell morphologies 
could be due to membrane blebbing, indicative of apoptosis leading to its death (Fig. 5). 
Antioxidant treatment strategies can increase hydrogen peroxide levels, scavenge reac-
tive oxygen species (ROS), and induce cancer cells to undergo apoptosis (Gorrini et al. 
2013; Trachootham et al. 2009). From, the experimental data, we could relate a similar 
mechanism operating in the death of cancer cells by the introduction of GNPs-Pep-A 
conjugate.
Conclusion
Functionalized nanomaterials have revolutionized the field of targeted cancer therapy. 
Cancer biomarkers or targets such as onco-proteins are targeted with the functionalized 
nanomaterials. This study emphasizes on targeting the ROS in Retinoblastoma (RB) can-
cer cells, and also on an in vitro model to deliver the antioxidant peptides. The results 
have demonstrated an effective system for ROS scavenging activity which induces the 
apoptosis in RB cancer cells. The observed results confirm the synergistic effect of the 
GNPs-Pep-A. The novel, multifunctionalized GNPs can be alternative candidates for 
cancer therapeutic strategy —such as those demonstrated in case of current study—the 
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self-therapeutic GNPs (such as V. vinifrea L. GNPs) and antioxidant peptides. Thus, the 
antioxidant-based therapy may improve response to the therapy, and therefore, in future, 
these novel GNPs-Pep-A can be promising nano biocomposites for targeting cancer 
Fig. 7 Cytotoxicity (MTT) assays with Pep-A and Pep-B. Cytotoxic effects of Peptide A and B analyzed at 
24 and 48 h in Y79 RB cells (a) and (b), and MIO-M1 non-neoplastic cells (c), which were found to show no 
cytotoxicity in vitro
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cells. Although the application of antioxidants is controversial in cancer treatment, the 
effect of antioxidant can minimize the side effect of chemotherapy, which in turn, can 
reduce the chemical toxicity, and may, therefore, enhance the degree of success during 
the course of treatment.
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